Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portions.
about
The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia.Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasiaSilodosin is effective for treatment of LUTS in men with BPH: a systematic reviewSilodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia.Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography.Silodosin in the treatment of benign prostatic hyperplasiaWithdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Correlation between lower urinary tract symptoms and premature ejaculation in Korean men older than 40 years old [corrected]The role of Silodosin as a new medical expulsive therapy for ureteral stones: a meta-analysis.Physiological and pharmacological aspects of the vas deferens-an updateTamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses.Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation?Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function.Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.Efficacy of alfuzosin after shock wave lithotripsy for the treatment of ureteral calculi.Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens.Terazosin-induced alterations in catalase expression and lipid peroxidation in the rat seminal vesicles.Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission.
P2860
Q33650768-FE8C72D5-89E8-4F2E-92A3-298D7F9D9C01Q34452517-58DEFB5B-5B46-458E-9ED7-76A6085BC05EQ34504207-9366C3F5-EA26-49CE-83B5-7786B05FB778Q34585420-4846395C-38C7-4F43-8BB1-273C3C3A272EQ34595957-93110DE2-2BB6-41AE-9AB8-DEDEE0BB153BQ34625490-2A917D19-FA04-4CA7-85D9-157295EFAFA7Q34653803-11BCEE5F-CFAC-4FEC-92A7-E8C629CFF63DQ35852000-D9417AAA-4DE1-4707-ADB2-4C887E485454Q36149318-33EE2E36-D4CC-4865-9869-BEF9F5BE7E3CQ37111681-CA1CDD8F-FD8F-4F89-803B-BFFB2B8DB15DQ37111860-2C2239E5-F511-43E5-A7F5-7C3EBA7AA75DQ37832643-2DECAEA6-0F53-437F-9DDF-89A7D58C745FQ38239520-226E16BB-374B-40AD-B488-4F3C4186EA57Q41192891-C0478350-3CB4-4FE6-B452-78DFA199F1CAQ42058962-01FA00E6-B267-43E2-B61C-1BA6D942BF6AQ43032713-8FB1ED32-144C-4163-9655-CA7EF7ED6FEEQ46686217-6FEADBEE-2345-4157-85FE-EAEA707E80A3Q53250512-9B150754-59C3-4E45-B90F-612DDB9E7B73Q54578773-7E30CF0A-6028-4656-9F4F-E4F80D425B26
P2860
Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portions.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Quantification and distributio ...... pididymal and pelvic portions.
@ast
Quantification and distributio ...... pididymal and pelvic portions.
@en
type
label
Quantification and distributio ...... pididymal and pelvic portions.
@ast
Quantification and distributio ...... pididymal and pelvic portions.
@en
prefLabel
Quantification and distributio ...... pididymal and pelvic portions.
@ast
Quantification and distributio ...... pididymal and pelvic portions.
@en
P2093
P356
P1476
Quantification and distributio ...... pididymal and pelvic portions.
@en
P2093
Moriyama N
Nishimatsu H
Takeuchi T
Tsujimoto G
P2860
P304
P356
10.1038/SJ.BJP.0701485
P407
P577
1997-11-01T00:00:00Z